Burning Rock Biotech (BNR) Total Liabilities (2019 - 2026)

Burning Rock Biotech (BNR) has reported Total Liabilities for 8 consecutive years, with $39.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Liabilities rose 0.89% year-over-year to $39.3 million; the TTM figure through Mar 2026 stood at $39.3 million (up 0.89% YoY), while the FY2025 annual figure was $40.8 million, down 2.26% from the prior year.
• Total Liabilities came in at $39.3 million for Q1 2026 at Burning Rock Biotech, down from $40.2 million in the prior quarter.
• The five-year high for Total Liabilities was $71.5 million in Q1 2022, with the low at $36.4 million in Q2 2025.
• Average Total Liabilities over 5 years is $47.5 million, with a median of $42.4 million recorded in 2024.
• Across the five-year window, Total Liabilities surged 34.31% in 2022 and tumbled 37.48% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $60.3 million in 2022, then sank by 37.48% to $37.7 million in 2023, then advanced by 12.37% to $42.4 million in 2024, then declined by 5.17% to $40.2 million in 2025, then retreated by 2.15% to $39.3 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $39.3 million, $40.2 million, and $36.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.